Statin prescribing in Australia: Socioeconomic and sex differences. A cross-sectional study

Medical Journal of Australia

Volumn 180, Issue 5, 2004, Pages 229-231

  Stocks, Nigel P ^a   Ryan, Philip ^a   McElroy, Heather ^a   Allan, James ^b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b Hills Medical Services   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; AUSTRALIA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; DRUG COST; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PRESCRIPTION; PREVALENCE; RISK BENEFIT ANALYSIS; SEX DIFFERENCE; SOCIOECONOMICS; STATISTICAL SIGNIFICANCE;

EID: 1542359950     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2004.tb05891.x     Document Type: Article

References (23)

1. Bennett S. Socioeconomic inequalities in coronary heart disease and stroke mortality among Australian men, 1979-1993. Int J Epidemiol 1996; 25: 266-275.
2. National Preventive and Community Medicine Committee RACGP. Guidelines for preventive activities in general practice. Aust Fam Physician 2002; 31(S1): 17-28.
3. Jackson R. Guidelines on preventing cardiovascular disease in clinical practice. BMJ 2000; 320: 659-661.
4. Fairhurst K, Huby G. From trial data to practical knowledge: qualitative study of how general practitioners have accessed and used evidence about statin drugs in their management of hypercholesterolaemia. BMJ 1998; 317: 1130-1134.
5. Grover S, Lowensteyn I, Esrey K, et al. Do doctors accurately assess coronary risk in their patients? Preliminary results of the coronary health assessment study. BMJ 1995; 310:975-978.
6. Taylor R, Chey T, Bauman A, Webster I. Socioeconomic, migrant and geographic differentials in coronary heart disease occurrence in New South Wales. Aust N Z J Public Health 1999; 23: 20-26.
7. Sexton PT, Sexton TH. Excess coronary mortality among Australian men and women living outside the capital city statistical divisions. Med J Aust 2000; 172: 370-374.
8. Health Insurance Commission. Pharmaceutical Benefits Scheme statistical report for items 8213G, 8214H, 8215J, 8521L, 8023G, 8024H, 2833D, 2834E, 8197K, 2013Y, 2011W, 2012X, 8173E, 8313M, by scheme by state. December 2002 to November 2003. Available at: www.hic.gov.au/statistics/dyns/forms/pbsb1.shtml (accessed Jan 2004).
9. Hippisley-Cox J, Pringle M, Crown N, et al. Sex inequalities in ischaemic heart disease in general practice: cross sectional survey. BMJ 2001; 322: 832.
10. Hart JT. The inverse care law. Lancet 1971;1:405-412.
11. Australian Bureau of Statistics. 1996 Census of Population and Housing: Socio-Economic Indexes for Areas [Information paper]. Canberra: ABS, 1998. (ABS Catalogue No. 2039.0).
12. Australian Bureau of Statistics. Population by age and sex, Australian states and territories. Canberra: ABS, 2003. (ABS Catalogue no. 3201.0.)
13. Australian Institute of Health and Welfare. Heart, stroke and vascular diseases - Australian facts 2001. Cardiovascular Disease Series No. 14. Canberra: AIHW, National Heart Foundation of Australia, National Stroke Foundation of Australia, 2001. (AIHW Catalogue No. CVD13.)
14. SAS [computer program]. Version 8.02. Cary, NC: SAS Institute Inc, 1999.
15. Australian Bureau of Statistics. National Health Survey: summary of results. Canberra: ABS, 2001. (ABS Catalogue No. 4364.0).
16. McIsaac W, Goel V, Naylor D. Socio-economic status and visits to physicians by adults in Ontario, Canada. J Health Serv Res Policy 1997; 2: 94-102.
17. Furler JS, Harris E, Chondros P, et al. The inverse care law revisited: impact of disadvantaged location on accessing longer GP consultation times. Med J Aust 2002; 177: 80-83.
18. Commonwealth Department of Health and Aged Care. General practice in Australia: 2000. Canberra: Commonwealth Department of Health and Aged Care, 2000.
19. Henderson J, Pan Y, Britt H, et al. Cardiovascular problems and risk behaviours among patients at general practice encounters in Australia 1998-00. General Practice Series No. 9. Canberra: AIHW, 2002. (AIHW Catalogue No. GEP 9.).
20. Barter P, Best P, Boyden A, et al. Lipid management guidelines - 2001. Med J Aust 2001; 175 (Suppl): S61-S84. Available at: www.heartfoundation.com.au/downloads/lipidide01.pdf (accessed Jan 2004).
21. Forge BH, Briganti EM. Lipid lowering and coronary heart disease risk: how appropriate are the national guidelines? Med J Aust 2001; 175: 471-475.
22. Simons LA, Levis G, Simons J. Apparent discontinuation rates in patients prescribed lipid-lowering drugs. Med J Aust 1996; 164: 208-211.
23. McElduff P, Dobson AJ. Trends in coronary heart disease - has the socio-economic differential changed? Aust N Z J Public Health 2000; 24: 465-473.